Full Text View
Tabular View
No Study Results Posted
Related Studies
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease (ACORD)
This study is currently recruiting participants.
Study NCT00117936   Information provided by CardioVascular BioTherapeutics, Inc.
First Received: June 30, 2005   Last Updated: August 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Disease
Coronary Heart Disease
Myocardial Ischemia
Coronary Arteriosclerosis
Additional conditions recognized in this trial
Arteriosclerosis
Coronary Artery Disease
Heart Diseases
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Cardiovascular Diseases
Pathologic Processes
Vascular Diseases
Additional drug interventions recognized in this trial
Mitogens
More general drug interventions related to this trial
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
CardioVascular BioTherapeutics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services